Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Anti-Aging
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Obagi Medical Products presents promising in vitro data for topical C serums
Chicago - Obagi Medical Products announces in vitro data showing that Obagi-C Rx Serum provided more than 10 times the absorption of vitamin C than the leading competitive product, Skinceuticals, according to Marketwatch.com.
Chicago
- Obagi Medical Products announces
in vitro
data showing that Obagi-C Rx Serum provided more than 10 times the absorption of vitamin C than the leading competitive product, according to Marketwatch.com.
In addition, the Obagi Professional-C Serum had a five-fold greater absorption of vitamin C than the leading competitive product, and both Obagi products were proven to have a greater stability than the leading competitor.
Related Videos
Related Content
